aluates Reports

$ 0.0

Automative

Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Research Report 2026

Published Date: 2026-04-20

Report Code: QYRE-Auto-34A13004

Global Biosynthetic Human Milk Oligosaccharides HMOs Market Research Report 2023

BUY CHAPTERS

Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Research Report 2026

Code: QYRE-Auto-34A13004

Report

2026-04-20

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Chr. Hansen (Jennewein)

Abbott

FrieslandCampina

DSM (Glycom)

Dupont (Inbiose)

BASF AG

Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size

The global Biosynthetic Human Milk Oligosaccharides (HMOs) market was valued at US$ 860 million in 2025 and is anticipated to reach US$ 3919 million by 2032, at a CAGR of 24.6% from 2026 to 2032.

Biosynthetic Human Milk Oligosaccharides (HMOs) Market

Biosynthetic Human Milk Oligosaccharides (HMOs) are complex carbohydrates naturally found in human breast milk that play a crucial role in infant nutrition and health. These oligosaccharides are not directly digestible by infants but act as prebiotics to promote the growth of beneficial gut bacteria, support immune function, and help develop a healthy gut microbiome. HMOs are one of the key components that differentiate human milk from the milk of other mammals, with over 200 different types of HMO identified in breast milk, whereas other mammalian milk contains only small amounts of HMOs.

In recent years, the biosynthetic production of HMOs has advanced, enabling the inclusion of these beneficial compounds in infant formulas. By mimicking the composition of human breast milk, biosynthetic HMOs aim to replicate the health benefits traditionally associated with breastfeeding. These biosynthetic HMOs are typically produced at a large scale using genetically engineered microbes through fermentation processes, overcoming the limitation of traditional dairy products that do not contain these important carbohydrates. 2'-Fucosyllactose (2'-FL) is a key HMO found in human milk and has been shown to play a significant role in gut health, immune system development, and protection against infections.

With the global increasing focus on infant health, immune function, and gut health, the market for biosynthetic HMOs is showing significant potential. In emerging markets such as China, India, and other regions, as living standards improve and greater attention is paid to infant health and nutrition, the demand for HMOs is steadily growing. As a natural ingredient found in breast milk, HMOs are seen as a way to mimic the beneficial components of breast milk, which has led to a broadening of their application scenarios. HMOs are not only widely used in infant formula but are also receiving growing attention in adult health, functional foods, and pharmaceuticals.

Furthermore, the growing recognition of the benefits of breastfeeding, coupled with increasing consumer awareness of infant health, contributes to the expanding market for biosynthetic HMOs. As biotechnology advances, production processes have become more cost-effective, further enhancing the market development potential.

Market Risks

Despite the promising market opportunities, the biosynthetic HMO industry faces several challenges. First, the production of HMOs is still relatively complex and costly. Although production techniques are improving, the price of HMOs remains relatively high compared to traditional dairy products, which may hinder their adoption in lower-income markets.

Second, there are high technological barriers in HMO production. The production process involves advanced biotechnologies such as genetic engineering and fermentation techniques, which means that only a few large companies and research institutions can effectively master these technologies, resulting in a relatively high level of market concentration.

Finally, with the market’s expansion, regulatory challenges may arise. HMOs have wide-ranging biological functions and applications, which may subject them to varying regulations in different countries and regions, creating uncertainty in market development.

Market Concentration

Currently, the biosynthetic HMO market has a high concentration, mainly dominated by a few companies with advanced production technologies. These companies typically have strong R&D capabilities and production facilities to ensure product quality and consistency. However, with the widespread adoption of biotechnology and the increase in competition, market dynamics are expected to become more competitive, providing opportunities for emerging companies to enter the market through technological innovations and cost management.

Downstream Demand Trends

The downstream demand for biosynthetic HMOs primarily comes from the infant formula market and the adult functional food market. The infant formula market remains the largest source of demand, and with global demographic changes and updated parenting practices, the demand for infant formula continues to grow. Additionally, with increasing consumer interest in health, the adult functional food market has also become an important application area for HMOs. Particularly in gut health, immune system enhancement, and neurological protection, HMOs as a functional food ingredient have tremendous market potential.

Latest Technologies

Recent technological advancements in the field of biosynthetic HMO production are centered around fermentation technology and genetic engineering applications. Fermentation technology has become an efficient and cost-effective method for producing HMOs. Through microbial fermentation, large quantities of HMOs can be produced in a relatively short period, and the production cost can be significantly reduced. Additionally, innovations in genetic engineering technologies have made the HMO synthesis process more precise, enabling the customization of specific types of HMOs to meet market demands for particular functions.

With ongoing advancements in technology, the production process for HMOs is expected to become even more streamlined, and production costs are likely to decline further, which will drive the widespread application of HMOs globally.

This report delivers a comprehensive overview of the global Biosynthetic Human Milk Oligosaccharides (HMOs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biosynthetic Human Milk Oligosaccharides (HMOs). The Biosynthetic Human Milk Oligosaccharides (HMOs) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Biosynthetic Human Milk Oligosaccharides (HMOs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Biosynthetic Human Milk Oligosaccharides (HMOs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Biosynthetic Human Milk Oligosaccharides (HMOs) Market Report

Report Metric	Details
Report Name	Biosynthetic Human Milk Oligosaccharides (HMOs) Market
Accounted market size in 2025	US$ 860 million
Forecasted market size in 2032	US$ 3919 million
CAGR	24.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	2'-FL & 3-FL LNT & LNnT, etc.
Segment by Application	Infant Formula Other Applications
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Dupont (Inbiose), DSM (Glycom), Chr. Hansen (Jennewein), BASF, FrieslandCampina
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Biosynthetic Human Milk Oligosaccharides (HMOs) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Biosynthetic Human Milk Oligosaccharides (HMOs) Market growing?

Ans: The Biosynthetic Human Milk Oligosaccharides (HMOs) Market witnessing a CAGR of 24.6% during the forecast period 2026-2032.

What is the Biosynthetic Human Milk Oligosaccharides (HMOs) Market size in 2032?

Ans: The Biosynthetic Human Milk Oligosaccharides (HMOs) Market size in 2032 will be US$ 3919 million.

Who are the main players in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market report?

Ans: The main players in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market are Abbott, Dupont (Inbiose), DSM (Glycom), Chr. Hansen (Jennewein), BASF, FrieslandCampina

What are the Application segmentation covered in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market report?

Ans: The Applications covered in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market report are Infant Formula, Other Applications

What are the Type segmentation covered in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market report?

Ans: The Types covered in the Biosynthetic Human Milk Oligosaccharides (HMOs) Market report are 2'-FL & 3-FL, LNT & LNnT, etc.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 2'-FL & 3-FL

1.2.3 LNT & LNnT, etc.

1.3 Market by Application

1.3.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Infant Formula

1.3.3 Other Applications

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Perspective (2021–2032)

2.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Growth Trends by Region

2.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Region (2021–2026)

2.2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2027–2032)

2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Dynamics

2.3.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Industry Trends

2.3.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers

2.3.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges

2.3.4 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue

3.1.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue (2021–2026)

3.1.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Players (2021–2026)

3.2 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue

3.4 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio

3.4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2025

3.5 Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs) Head Offices and Areas Served

3.6 Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs), Products and Applications

3.7 Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Type

4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Type (2021–2026)

4.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2027–2032)

5 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Application

5.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Application (2021–2026)

5.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2021–2032)

6.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2021–2026)

6.4 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2021–2032)

7.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2021–2026)

7.4 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2021–2032)

8.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2021–2026)

8.4 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2021–2032)

9.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2021–2026)

9.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2021–2032)

10.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2021–2026)

10.4 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.1.4 Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.1.5 Abbott Recent Development

11.2 Dupont (Inbiose)

11.2.1 Dupont (Inbiose) Company Details

11.2.2 Dupont (Inbiose) Business Overview

11.2.3 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.2.4 Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.2.5 Dupont (Inbiose) Recent Development

11.3 DSM (Glycom)

11.3.1 DSM (Glycom) Company Details

11.3.2 DSM (Glycom) Business Overview

11.3.3 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.3.4 DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.3.5 DSM (Glycom) Recent Development

11.4 Chr. Hansen (Jennewein)

11.4.1 Chr. Hansen (Jennewein) Company Details

11.4.2 Chr. Hansen (Jennewein) Business Overview

11.4.3 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.4.4 Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.4.5 Chr. Hansen (Jennewein) Recent Development

11.5 BASF

11.5.1 BASF Company Details

11.5.2 BASF Business Overview

11.5.3 BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.5.4 BASF Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.5.5 BASF Recent Development

11.6 FrieslandCampina

11.6.1 FrieslandCampina Company Details

11.6.2 FrieslandCampina Business Overview

11.6.3 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction

11.6.4 FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

11.6.5 FrieslandCampina Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Chr. Hansen (Jennewein)

Abbott

FrieslandCampina

DSM (Glycom)

Dupont (Inbiose)

BASF AG

List of Tables

Table 1. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of 2'-FL & 3-FL

Table 3. Key Players of LNT & LNnT, etc.

Table 4. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (US$ Million), 2021–2026

Table 7. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2021–2026)

Table 8. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2027–2032)

Table 10. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Trends

Table 11. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers

Table 12. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges

Table 13. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints

Table 14. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Players (US$ Million), 2021–2026

Table 15. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Players (2021–2026)

Table 16. Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue, 2025

Table 17. Ranking of Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs), Headquarters and Area Served

Table 20. Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs), Products and Applications

Table 21. Global Key Players of Biosynthetic Human Milk Oligosaccharides (HMOs), Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (US$ Million), 2021–2026

Table 24. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2021–2026)

Table 25. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2027–2032)

Table 27. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (US$ Million), 2021–2026

Table 28. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2021–2026)

Table 29. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2027–2032)

Table 31. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2021–2026

Table 33. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (US$ Million), 2027–2032

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 49. Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 50. Abbott Recent Development

Table 51. Dupont (Inbiose) Company Details

Table 52. Dupont (Inbiose) Business Overview

Table 53. Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 54. Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 55. Dupont (Inbiose) Recent Development

Table 56. DSM (Glycom) Company Details

Table 57. DSM (Glycom) Business Overview

Table 58. DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 59. DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 60. DSM (Glycom) Recent Development

Table 61. Chr. Hansen (Jennewein) Company Details

Table 62. Chr. Hansen (Jennewein) Business Overview

Table 63. Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 64. Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 65. Chr. Hansen (Jennewein) Recent Development

Table 66. BASF Company Details

Table 67. BASF Business Overview

Table 68. BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 69. BASF Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 70. BASF Recent Development

Table 71. FrieslandCampina Company Details

Table 72. FrieslandCampina Business Overview

Table 73. FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Product

Table 74. FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (US$ Million), 2021–2026

Table 75. FrieslandCampina Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Biosynthetic Human Milk Oligosaccharides (HMOs) Picture

Figure 2. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type: 2025 vs 2032

Figure 4. 2'-FL & 3-FL Features

Figure 5. LNT & LNnT, etc. Features

Figure 6. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application: 2025 vs 2032

Figure 8. Infant Formula Case Studies

Figure 9. Other Applications Case Studies

Figure 10. Biosynthetic Human Milk Oligosaccharides (HMOs) Report Years Considered

Figure 11. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region: 2025 vs 2032

Figure 14. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Players in 2025

Figure 15. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2025

Figure 17. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2021–2032)

Figure 19. United States Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2021–2032)

Figure 23. Germany Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2021–2032)

Figure 31. China Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2021–2032)

Figure 39. Mexico Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2021–2032)

Figure 43. Israel Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Abbott Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 47. Dupont (Inbiose) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 48. DSM (Glycom) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 49. Chr. Hansen (Jennewein) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 50. BASF Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 51. FrieslandCampina Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2021–2026)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Milk Oligosaccharides Market Research Report 2024

Global Human Milk Oligosaccharides in Infant Formula Market Research Report 2024

Global Sialylated Human Milk Oligosaccharides HMO Market Research Report 2024

Global 6 Sialyllactose 6 SL Market Research Report 2024

Global HMO Formula Milk Market Research Report 2024

Global Probiotics for Infants and Women Market Research Report 2025

Global HMO Children s Milk Powder Market Research Report 2024

Global HMO Children s Formula Milk Powder Market Research Report 2024

Global Oligosaccharides in Infant Nutrition Market Insights Forecast to 2030

Global Soy Infant Formula Market Research Report 2025

Global HMO Milk Powder Market Research Report 2024

Global Mannan oligosaccharide MOS Market Research Report 2024

Global Adult Nutritional Milk Powder Market Research Report 2025

Global HMO Infant Formula Market Research Report 2025

Global Lacto N tetraose LNT and Lacto N neotetraose LNnT Market Research Report 2024

Global Galacto oligosaccharide Market Research Report 2025

Global HMO Toddler Formula Milk Powder Market Research Report 2024

Lactulose Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bifidobacterium Longum Subsp Infantis M 63 Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions